Founded in 2020, Ester Laps OÜ has primarily focused on research and scientific activities in the application of ethyl monoesers of Omega-3 acids in cosmetology. These compounds are positioned as a safe alternative to steroid, antibiotic, or retinoid therapies in the prevention of conditions such as atopic dermatitis (AD), seborrheic dermatitis (SD), and psoriasis.
The result of several years of work is the first cosmetic product to be developed, implemented, and patented: Alaceum® PRO.
The development of additional products in this group, based on Omega-3 monoesers (essentiALA), is at an advanced stage, with further launches planned in the near future.
Founded in 2020, Ester Laps OÜ has primarily focused on research and scientific activities in the application of ethyl monoesers of Omega-3 acids in cosmetology. These compounds are positioned as a safe alternative to steroid, antibiotic, or retinoid therapies in the prevention of conditions such as atopic dermatitis (AD), seborrheic dermatitis (SD), and psoriasis.
The result of several years of work is the first cosmetic product to be developed, implemented, and patented: Alaceum® PRO.
The development of additional products in this group, based on Omega-3 monoesers (essentiALA), is at an advanced stage, with further launches planned in the near future.
Monoesters of higher Omega 3, 6, and 9 fatty acids derived from flaxseed (essentiALA) penetrate deep into the skin, supporting its proper cellular function. They exhibit anti-inflammatory properties, stimulate regeneration, and are essential for rebuilding the skin’s natural hydro-lipid barrier.
Omega 3 and 6 (a-linolenic acid, linoleic acid, y-linolenic acid) improve skin hydration, reduce the feeling of roughness and tightness, and decrease the tendency for adverse epidermal changes. Omega 3 and 6 are absorbed by the stratum corneum and integrate into the intercellular cement, reducing water loss through the skin. They enhance skin elasticity and restore a healthy appearance.
Omega 9 (oleic acid) provides moisturizing and softening properties for the epidermis.
Alaceum® PRO has proven to be a breakthrough, opening a new chapter in the fight against skin diseases affecting nearly 30% of citizens in developed countries. This patented formulation has demonstrated effectiveness in combating atopic dermatitis (AD), seborrheic dermatitis (SD), psoriasis, and other inflammatory skin conditions of various origins. With an efficacy rate exceeding 80%, it’s high time to find solutions for the remaining 20%. That’s exactly what we’re focused on now. Building on the unprecedented effectiveness of essentiALA monoesers, we are developing new formulations capable of addressing skin inflammation in even the most treatment-resistant cases.
Alaceum® PRO was first introduced to the Polish market because Poland was the first country where we secured a patent for our formulation. Soon, we expect to receive patent protection in 26 additional markets!
Alaceum® PRO quickly became an official partner of the Polish Society of Atopic Diseases (PTCA) and rapidly gained recognition within the dermatology community in Poland, earning top ratings from users.
Now, it’s time for European and global expansion. If you’re interested in bringing Alaceum® PRO to new markets, contact us today!
Ester Labs OÜ
Harju maakond, Tallinn, Kesklinna linnaosa, Sakala tn 7-2,
10141 Estonia
Registrikood 16103618
VAT EE102314694
Next Trade Group Sp. z o.o.
Al. Jana Pawła II 27
00-867 Warszawa
NIP 6572829375